lanthanum has been researched along with losartan potassium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Kitai, M; Maruyama, N; Maruyama, T; Nagura, C; Otsuki, T; Shibahara, N; Tomita, H; Yoshida, Y | 1 |
1 trial(s) available for lanthanum and losartan potassium
| Article | Year |
|---|---|
Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.
Topics: Erythropoietin; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Lanthanum; Male; Middle Aged; Prospective Studies; Renal Dialysis; Treatment Outcome | 2018 |